Floatz logo

URSODEOXYCHOLIC ACID

Huntington Disease

Oregon Health and Science UniversitySmall moleculePhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

25 Active assets in the Huntington Disease cohort.

Asset / SponsorPhaseRating
Deutetrabenazine
Teva Branded Pharmaceutical Products R&D LLC
Phase 4BBB
Tetrabenazine
William Ondo, MD
Phase 4BBB
ro7234292
Hoffmann-La Roche
Phase 3BBB
Dimebon
Medivation, Inc.
Phase 3BB
Pridopidine
Prilenia
Phase 3BB

View all 50 →

Same molecule, other indications

URSODEOXYCHOLIC ACID is also rated in:

primary biliary cholangitisDormant
A
Indicative ·
82 / 100
View asset →
Nonalcoholic Steatohepatitis (NASH)Dormant
BBB
Indicative ·
74 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →